Sublingual misoprostol vs intravenous ergometrine for the prevention of postpartum haemorrhage in women undergoing Caeserean section

Trial Profile

Sublingual misoprostol vs intravenous ergometrine for the prevention of postpartum haemorrhage in women undergoing Caeserean section

Completed
Phase of Trial: Phase IV

Latest Information Update: 22 May 2013

At a glance

  • Drugs Misoprostol (Primary) ; Ergometrine
  • Indications Postpartum haemorrhage
  • Focus Therapeutic Use
  • Most Recent Events

    • 22 May 2013 New trial record
    • 08 May 2013 Results presented at the 61st Annual Clinical Meeting of the American College of Obstetricians and Gynecologists.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top